Drug delivery vs drops: Controlling postop pain, inflammation in cataract patients
John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.
Video Player is loading.
John A. Hovanesian, MD, clinical instructor, UCLA Jules Stein Eye Institute, Laguna Hills, CA, discusses the highlights of his presentation titled "The D3 Study: Drug Delivery vs Drops — A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery," during the virtual 2020 American Academy of Ophthalmology (AAO) meeting.
Recent Videos
Impact of Durable Therapies on Patients and Clinics and Monitoring Strategies
Snowmass Retina & Eye 2025: Ronald Frenkel, MD, previews the unique agenda with a fusion of retina, cataract, and glaucoma
Strategies for Loading Dose Sse for Treatment-Naive and Switch Patients
Perspectives on the Usefulness of Real-world Data
Safety Profile of New Therapies
Outcomes with Faricimab and Choosing Between the New Therapies
Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal Diseases
Faricimab Molecular Design and Role of Ang-2
Adverse Events of the Port Delivery System and Addressing Challenges with Adoption
Related Content
